// App-Quantinova.ai

: 4 Co-Crystal of Tramadol-Celecoxib: Efficacy and Safety Results from a Dose-Finding, Randomized, Double-blind, Multicenter, Phase II Clinical Trial in Patients With Moderate-To-Severe Acute Pain Due To an Oral Surgical Procedure

Researchers

Presenter

  • Jose Lopez Cendrun

Principal Investigators

  • Sebastian Videla

  • Miguel Burgueno

  • Inma Juarez

  • Samir Aboul-Hosn

  • Rafael Martin-Granizo

  • Joan Grau

  • Miguel Puche

  • Jose-Luis Gil-Diez

  • Jose-Antonio Hueto

  • Anna Vaque

  • Mariano Sust

  • Adelaida Morte

  • Jesus Cebrecos

  • Esther Ortiz

  • Carlos Plata-Salaman

  • Antoni Monner

Medical Centers

  • Hospital Universitario del Mar, Barcelona, Spain

  • Hospital General de Granollers, Granollers, Barcelona, Spain

  • Bellvitge University Hospital-IDIBELL, Barcelona, Spain

  • Hospital Del Mar, Barcelona, Spain

  • Esteve Pharmaceuticals S.A., Barcelona, Spain

  • Complejo Hospitalario Universitario de A Coruna, A Coruna, Spain

  • Hospital Clinico Universitario San Carlos, Madrid, Spain

  • Hospital Universitario del Mar, Barcelona, Spain

  • Hospital Universitario La Paz, Madrid, Spain

  • Hospital Clinico Valencia, Valencia, Spain

  • Hospital Universitario La Paz, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • E58425

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A